119 related articles for article (PubMed ID: 7014059)
1. Bone metastases studied in experimental animals.
Galasko CS
Clin Orthop Relat Res; 1981; (155):269-85. PubMed ID: 7014059
[No Abstract] [Full Text] [Related]
2. Bone metastases studied by experimental models.
Galasko CS
Schweiz Med Wochenschr; 1981 Dec; 111(49):1862-8. PubMed ID: 7330640
[No Abstract] [Full Text] [Related]
3. Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.
Galasko CS; Rawlins R; Bennett A
Br J Cancer; 1979 Sep; 40(3):360-4. PubMed ID: 508564
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lytic and blastic metastatic disease of bone.
Galasko CS
Clin Orthop Relat Res; 1982 Sep; (169):20-7. PubMed ID: 7105580
[TBL] [Abstract][Full Text] [Related]
5. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.
Galasko CS; Samuel AW; Rushton S; Lacey E
Br J Surg; 1980 Jul; 67(7):493-6. PubMed ID: 7417751
[TBL] [Abstract][Full Text] [Related]
6. In vitro osteolysis by human breast tumours.
Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM
Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116
[No Abstract] [Full Text] [Related]
7. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.
Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L
Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092
[TBL] [Abstract][Full Text] [Related]
8. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.
Galasko CS; Bennett A
Nature; 1976 Oct; 263(5577):508-10. PubMed ID: 972698
[No Abstract] [Full Text] [Related]
9. Patterns and mechanisms of bone metastases.
Carter RL
J R Soc Med; 1985; 78 Suppl 9(Suppl 9):2-6. PubMed ID: 4045915
[No Abstract] [Full Text] [Related]
10. Prostaglandins and hypercalcemic states.
Seyberth HW; Raisz LG; Oates JA
Annu Rev Med; 1978; 29():23-9. PubMed ID: 348034
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
Powles TJ
Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867
[No Abstract] [Full Text] [Related]
12. Prostaglandins, calcium metabolism and cancer.
Tashjian AH; Voelkel EF; Goldhaber P; Levine L
Fed Proc; 1974 Jan; 33(1):81-6. PubMed ID: 4203957
[No Abstract] [Full Text] [Related]
13. [Diphosphonates in the treatment of bone metastases].
Jung A; Fleisch H
Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of bone remodeling induced by tumors: tumor humors.
Tashjian AH
Schweiz Med Wochenschr; 1981 Dec; 111(49):1869-72. PubMed ID: 6800026
[No Abstract] [Full Text] [Related]
15. Prostaglandins and cancer.
Smith BJ; Wills MR; Savory J
Ann Clin Lab Sci; 1983; 13(5):359-65. PubMed ID: 6357045
[TBL] [Abstract][Full Text] [Related]
16. Bone metastasis: can osteoclasts be excluded?
Martin TJ; Mundy GR
Nature; 2007 Feb; 445(7130):E19; discussion E19-20. PubMed ID: 17314931
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow.
Otsuka N; Ito Y; Nagai K; Terashima H; Yanagimoto S; Muranaka A
J Nucl Med; 1981 May; 22(5):433-40. PubMed ID: 6452515
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of bone destruction in the development of skeletal metastases.
Galasko CS
Nature; 1976 Oct; 263(5577):507-8. PubMed ID: 972697
[No Abstract] [Full Text] [Related]
19. Effects of VX-2 carcinoma implanted in bone in rabbits.
Enneking WF; Flynn L
Cancer Res; 1968 Jun; 28(6):1007-13. PubMed ID: 5658436
[No Abstract] [Full Text] [Related]
20. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
Lynch CC
Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
